Genetics
Review catalogs ten CETP mutations behind hyperalphalipoproteinemia in Japanese CETP-deficient subjects (J Atheroscler Thromb 2004)
Original title: Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese
This review characterizes CETP deficiency, the most common cause of marked hyperalphalipoproteinemia (HALP) in Japanese populations, describing ten CETP gene mutations identified as causes, including the two most common: an intron 14 splicing defect (Int14+1 G to A) and an exon 15 missense mutation (D442G). CETP-deficient subjects show abnormalities in HDL and LDL concentration, composition, and function, representing impaired reverse cholesterol transport that may promote atherosclerosis despite high HDL cholesterol. The review notes epidemiological studies in Hawaiian Japanese-Americans and Japan's Omagari area, where the intron 14 splicing defect is markedly frequent, found relatively increased coronary atherosclerosis in CETP deficiency, contrasting with the TaqIB B2 allele's association with lower CETP mass, higher HDL cholesterol, and decreased CHD risk in studies including the Framingham Offspring Study.
Original abstract
Plasma cholesteryl ester transfer protein (CETP) facilitates the transfer of cholesteryl ester (CE) from high density lipoprotein (HDL) to apolipoprotein B-containing lipoproteins. Since CETP regulates the plasma levels of HDL cholesterol and the size of HDL particles, CETP is considered to be a key protein in reverse cholesterol transport (RCT), a protective system against atherosclerosis. The importance of plasma CETP in lipoprotein metabolism was demonstrated by the discovery of CETP-deficient subjects with marked hyperalphalipoproteinemia (HALP). Genetic CETP deficiency is the most important and common cause of HALP in the Japanese. Ten mutations of the CETP gene have been demonstrated as causes of HALP, including two common mutations: an intron 14 splicing defect (Int14 + 1 G --> A) and an exon 15 missense mutation (D442G). The subjects with CETP deficiency show a variety of abnormalities in the concentration, composition, and function of both HDL and low density lipoprotein (LDL). CETP deficiency is considered a physiological state of impaired RCT, which may possibly lead to the development of atherosclerosis despite high HDL cholesterol levels. However, the pathophysiological significance of CETP in terms of atherosclerosis has been controversial. Epidemiological studies in Japanese-Americans living in Hawaii and Japanese in the Omagari area, where HALP subjects with an intron 14 splicing defect of the CETP gene are markedly frequent, have shown a relatively increased incidence of coronary atherosclerosis in CETP deficiency. On the other hand, the TaqIB polymorphism-B2 allele with low CETP mass and increased HDL cholesterol has been related to a decreased risk for coronary heart disease (CHD) in many studies, including the Framingham Offspring Study. The current review focused on the characterization of the Japanese subjects with CETP deficiency, including our recent findings.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.